A detailed history of First Eagle Investment Management, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, First Eagle Investment Management, LLC holds 594,314 shares of CDNA stock, worth $13.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
594,314
Previous 968,552 38.64%
Holding current value
$13.7 Million
Previous $15 Million 23.36%
% of portfolio
0.04%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$14.41 - $33.99 $5.39 Million - $12.7 Million
-374,238 Reduced 38.64%
594,314 $18.6 Million
Q2 2024

Aug 12, 2024

SELL
$7.56 - $16.15 $276,355 - $590,363
-36,555 Reduced 3.64%
968,552 $15 Million
Q1 2024

May 09, 2024

SELL
$7.96 - $12.37 $1 Million - $1.56 Million
-126,100 Reduced 11.15%
1,005,107 $10.6 Million
Q4 2023

Feb 08, 2024

BUY
$4.9 - $12.86 $617,488 - $1.62 Million
126,018 Added 12.54%
1,131,207 $13.6 Million
Q3 2023

Nov 08, 2023

BUY
$7.0 - $11.26 $1.96 Million - $3.16 Million
280,345 Added 38.68%
1,005,189 $7.04 Million
Q2 2023

Aug 09, 2023

BUY
$7.61 - $9.46 $1.53 Million - $1.91 Million
201,477 Added 38.5%
724,844 $6.16 Million
Q1 2023

May 11, 2023

BUY
$8.83 - $17.61 $2.22 Million - $4.43 Million
251,692 Added 92.64%
523,367 $4.78 Million
Q4 2022

Feb 09, 2023

BUY
$10.88 - $20.05 $642,289 - $1.18 Million
59,034 Added 27.76%
271,675 $3.1 Million
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $1.05 Million - $1.72 Million
65,190 Added 44.21%
212,641 $3.62 Million
Q2 2022

Aug 10, 2022

BUY
$20.49 - $39.72 $1.87 Million - $3.63 Million
91,276 Added 162.49%
147,451 $3.17 Million
Q1 2022

May 11, 2022

BUY
$28.19 - $46.6 $1.58 Million - $2.62 Million
56,175 New
56,175 $2.08 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.24B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.